Cochrane · systematic review · CD015187
Pharmacological interventions for prophylaxis of vestibular migraine
Webster, KE, Dor, A, Galbraith, K, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
5
No studies
2
Included studies
NR
No studies 2 · 28.6%Ungraded 0 · 0%Very low 4 · 57.1%Low 1 · 14.3%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Beta‐blockers compared to placebo for prophylaxis of vestibular migraine
Population: people with vestibular migraine
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Improvement in vertigo Beta‐blockers vs placebo | no estimate extracted | NR | No studies |
Change in vertigo frequency Beta‐blockers vs placebo | no estimate extracted | 1 study · 114 participants | Low Downgraded: risk of bias |
Serious adverse events Beta‐blockers vs placebo | RR 0.63 [0.24, 1.67] | 1 study · 121 participants | Very low Downgraded: risk of bias |
Calcium channel blockers compared to no intervention for prophylaxis of vestibular migraine
Population: people with vestibular migraine
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Improvement in vertigo severity Calcium channel blockers vs no intervention | RR 1.45 [1.01, 2.07] | 1 study · 48 participants | Very low Downgraded: risk of bias |
Improvement in vertigo frequency Calcium channel blockers vs no intervention | RR 1.65 [0.8, 3.41] | 1 study · 23 participants | Very low Downgraded: risk of bias, imprecision |
Change in vertigo frequency Calcium channel blockers vs no intervention | no estimate extracted | 1 study · 23 participants | Very low Downgraded: risk of bias, imprecision |
Serious adverse events Calcium channel blockers vs no intervention | no estimate extracted | NR | No studies |